Advanced Search

 

Study ID Status Title Patient Level Data
FNS30003 Completed Multicentre, Randomised, Double-blind, parallel group study to evaluate the efficacy of fluticasone propionate aqueous nasal spray associated with antibiotic therapy in the treatment of patients with acute rhino-sinusitis.
FPD40001 Completed A Comparison of fluticasone propionate (250µg bid) therapy via the new Diskus® dry powder inhaler to standard therapy (usual inhaled steroid via an alternate dry powder inhaler) in patients with moderate asthma.
FPD40009 Completed A Randomized, Double-Blind, Parallel Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate Inhalation Powder (250mcg QD) and Placebo in Subjects at Least 12 Years of Age with Chronic Asthma Currently Receiving Short Acting Beta Agonist Alone Study Listed on ClinicalStudyDataRequest.com
FPD40010 Completed A Randomized, Double-Blind, Parallel Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate Inhalation Powder (250mcg QD) and Placebo in Subjects at Least 12 Years of Age with Chronic Asthma Currently Treated with Inhaled Corticosteroids Study Listed on ClinicalStudyDataRequest.com
FPD40012 Completed A Randomized, Double-Blind, Double-Dummy, Parallel Group Comparison of Fluticasone Propionate Inhalation Powder (50mcg BID) with Oral Montelukast (5mg QD) in Children 6-12 Years of Age with Persistant Asthma Study Listed on ClinicalStudyDataRequest.com
FPD40013 Completed A Randomized, Double-Blind, Double-Dummy, Parallel Group Comparison of Fluticasone Proprionate Inhalation Powder (50mcg BID) with Oral Montelukast (5mg QD) in Children 6-12 with Persistant Asthma Study Listed on ClinicalStudyDataRequest.com
FPD40014 Completed A Randomized, Double-Blind 12-Week Comparative Trial of Fluticasone Propionate DISKUS 100mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID And Oral Montelukast 10mg QD In Adults With Persistent Asthma. Study Listed on ClinicalStudyDataRequest.com
FPD40015 Completed A Randomized, Open-Label, Cross Over Trial, Assessing Ease of Use, Correctness of Use and Patient Preference of Fluticasone Propionate Inhalation Powder (100mcg BID) via the Diskus versus Fluticasone Propionate Aerosol via the Metered Dose Inhaler (88mcg BID) in Subjects at Least 12 Years of Age with Persistent Asthma Currently Receiving Short Acting Beta Agonists Alone Study Listed on ClinicalStudyDataRequest.com
FPD40016 Completed A Randomized, Open-Label, Cross Over Trial, Assessing Ease of use, Correctness of use and Patient Preference of Fluticasone Propionate Inhalation Powder (100mcg BID) via the DISKUS™ versus Fluticasone Propionate Aerosol via the Metered Dose Inhaler (88mcg BID) in Subjects at Least 12 Years of Age with Persistent Asthma Currently Receiving Short Acting Beta Agonists Alone. Study Listed on ClinicalStudyDataRequest.com
FPR10001 Completed A double blind, placebo controlled, single dose, crossover study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled reformulated FP (TIBAC) in comparison with the standard formulation FP. Study Listed on ClinicalStudyDataRequest.com
FPR10006 Completed A randomised, double blind, placebo controlled, cross over study to investigate the duration of action of inhaled doses of Fluticasone Propionate (1000mg) on airway responsiveness to adenosine-5'-monophosphate (AMP) in mild asthmatic patients Study Listed on ClinicalStudyDataRequest.com
FRX106365 Completed A randomized, controlled trial to evaluate the effects of nadroparin on survival and disease progression in patients with advanced malignancies of the lung, pancreas, or prostate Study Listed on ClinicalStudyDataRequest.com
FS12004 Completed Seretide efficacy and safety monitoring in Slovenia
G91-003 Completed A Pilot Study to Investigate Morning Plasma Cortisol Levels and Plasma FP Levels Following Single Doses of FP Administered by Nebuliser (0.2%, 2x0.2% and 0.4%) and Pressurized Inhaler (2mg)
GCP/95/045 Completed A study to investigate the pharmacokinetics of GG167 in subjects with impaired renal function.
GHP:87:19 Completed A Study To Evaluate The Effect Of Repeat Oral Dosing Of GR38032F At 8 Mg BD, 1 Mg BD And 0.25 Mg BD On Cognitive Function In Healthy Volunteers.
GHP:87:21 Completed A Study To Evaluate The Effect Of GR38032F On Psychomotor Performance After Repeat Oral Dosing In Healthy Volunteers.
GHP:90:19 Completed The Interaction Of Ondansetron And Temazepam.
GHP:90:26 Completed A Pilot Study to Assess the Systemic Effects of Single Doses of Fluticasone Propionate Administered as a Preservative Free Suspension by Nebuliser (0.05, 0.1, and 0.2%w/w in 2.5ml) and by Pressurised Inhaler (2mg)
GHP86:08 Completed To study plasma cortisol levels after a single 2 mg dose of intranasal fluticasone propionate (Part I). To compare the effect of repeated intranasal doses of fluticasone propionate and beclomethasone dipropionate (1 mg twice a day) on plasma cortisol levels – Part II.
GHP86:34 Completed Report of the tolerance of twice-daily intranasal spray administration of fluticasone propionate (200 mg b.d.) in healthy volunteers.
GHP89:01 Completed The systemic absorption of fluticasone propionate following single intranasal doses of 200 mg in volunteers under normal conditions and following allergen-induced rhinitis.
GHP89:45 Completed A study to investigate the plasma levels of fluticasone propionate following intranasal administration of a single 800 mcg dose and following twice daily dosing with 200 mcg.
GHP90:12 Completed To investigate plasma levels and effects on the HPA axis following intranasal administration of fluticasone propionate (1 mg bid for seven and a half days) in comparison with placebo.
GL/MIG/001/92 Completed A double-blind, general practice study to compare GR43175 with paracetamol and metoclopramide in the acute treatment of migraine.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.